CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Genstruct Applying Epistemics Approach To 'Molecular World' (BioWorld Today)
News | 01. 20. 2004
Genstruct Inc. is approaching a drug discovery obstacle in a thoroughly modern way, that is, with what it calls “logical models” of biological systems designed to uncover and define compound mechanisms of action and disease mechanisms.
